CG
ALBO

Cutler Group’s Albireo Pharma Inc ALBO Stock Holding History

Cutler Group’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-100
Closed -$1K – 5565
2022
Q3 		$1K Buy
+100
New +$2.07K ﹤0.01% 4802
2021
Q4 		– Sell
-100
Closed -$3K – 6424
2021
Q3 		$3K Buy
+100
New +$3.09K ﹤0.01% 4922
2020
Q4 		– Sell
-2,955
Closed -$98K – 5709
2020
Q3 		$98K Buy
+2,955
New +$86.1K 0.01% 1342
2017
Q2 		– Sell
-615
Closed -$14K – 7321
2017
Q1 		$14K Hold
615
– – ﹤0.01% 3747
2016
Q4 		$10K Sell
615
-237
-28% -$4.92K ﹤0.01% 4251
2016
Q3 		$11K Hold
852
– – ﹤0.01% 4152
2016
Q2 		$7K Hold
852
– – ﹤0.01% 4642
2016
Q1 		$8K Hold
852
– – ﹤0.01% 4385
2015
Q4 		$8K Buy
+852
New +$8.81K ﹤0.01% 4452

Other funds holding ALBO

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
DCMIC
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return

Cutler Group's ALBO Position: Q4 2022 in Review

Cutler Group sold out of Albireo Pharma Inc (ALBO) in Q4 2022, closing a stake of 100 shares — an estimated $1K sold.

Cutler Group first reported a position in ALBO in Q4 2015 and held it in 9 quarters. The position peaked at $98K in Q3 2020. 96 funds tracked by Wall St. Rank hold ALBO as of Q4 2022.

  • Cutler Group reported no remaining Albireo Pharma Inc position as of Q4 2022 after selling out during the quarter.
  • Cutler Group sold 100 Albireo Pharma Inc shares in Q4 2022, an estimated $1K.
  • Cutler Group first reported a position in Albireo Pharma Inc in Q4 2015 and held it in 9 quarters.
  • Cutler Group's Albireo Pharma Inc position peaked at $98K in Q3 2020.
  • 96 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q4 2022.

Based on Cutler Group's 13F filing for Q4 2022, filed 7 Feb 2023.